IP Library Patent Application 16942156
Patent Application
App. No. 16/942,156

ADENOVIRUS-ASSOCIATED VIRUSES SEPARATION METHOD

Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US None
App. No.
16/942,156
Abstract

Provided is a method of enriching full adenovirus-associated virus (AAV) capsids from a mixture of full AAV capsids and empty AAV capsids, the method comprising providing a sample comprising a mixture of full AAV capsids and empty AAV capsids, subjecting the sample to anion exchange chromatography comprising an elution buffer comprising an equilibration buffer and a salt-containing buffer in an initial ratio that provides an initial conductivity, and changing the ratio of the equilibration buffer and the salt-containing buffer to provide a step gradient conductivity increase of about 0.5-2.0 mS/cm in each step to elute empty AAV capsids and to provide a fluid enriched with full AAV capsids.

Claims (14)

1 . A method of enriching full adenovirus-associated virus (AAV) capsids from a mixture of full AAV capsids and empty AAV capsids, the method comprising

providing a sample comprising a mixture of full AAV capsids and empty AAV capsids,

subjecting the sample to anion exchange chromatography comprising an elution buffer comprising an equilibration buffer and a salt-containing buffer in an initial ratio that provides an initial conductivity in the range of about 0.5 mS/cm to about 10 mS/cm, and

changing the ratio of the equilibration buffer and the salt-containing buffer to provide a step gradient conductivity increase of about 0.5-2.0 mS/cm in each step to elute empty AAV capsids and to provide a fluid enriched with full AAV capsids.

2 . The method of claim 1 , wherein subjecting the sample to anion exchange chromatography comprises contacting a positively charged microporous membrane with the sample.

3 . The method of claim 1 , wherein a final step provides a conductivity of about 20 mS/cm.

4 . The method of claim 1 , wherein the initial ratio of equilibration buffer to salt-containing buffer is about 98.3:1.7.

5 . The method of claim 1 , wherein the final ratio of equilibration buffer to salt-containing buffer is about 81.5:18.5.

6 . The method of claim 2 , wherein a final step provides a conductivity of about 20 mS/cm.

7 . The method of claim 2 , wherein the initial ratio of equilibration buffer to salt-containing buffer is about 98.3:1.7.

8 . The method of claim 3 , wherein the initial ratio of equilibration buffer to salt-containing buffer is about 98.3:1.7.

9 . The method of claim 2 , wherein the final ratio of equilibration buffer to salt-containing buffer is about 81.5:18.5.

10 . The method of claim 3 , wherein the final ratio of equilibration buffer to salt-containing buffer is about 81.5:18.5.

11 . The method of claim 4 , wherein the final ratio of equilibration buffer to salt-containing buffer is about 81.5:18.5.

Assignments (2)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 22, 2023
From: PALL CORPORATION
To: CYTIVA US LLC
Reel/Frame 063144/0716 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 11, 2020
From: HEJMOWSKI, ADAM
To: PALL CORPORATION
Reel/Frame 053457/0041 →